[(3S)-1,3-dimethyl-3,4-dihydro-2H-1,5-benzodiazepin-5-yl]-(5-methylpyrazolo[1,5-a]pyrimidin-6-yl)methanone
C19H21N5O — CID 164625662
Data last refreshed: (MolForge compound catalog, from PubChem)
About [(3S)-1,3-dimethyl-3,4-dihydro-2H-1,5-benzodiazepin-5-yl]-(5-methylpyrazolo[1,5-a]pyrimidin-6-yl)methanone
[(3S)-1,3-dimethyl-3,4-dihydro-2H-1,5-benzodiazepin-5-yl]-(5-methylpyrazolo[1,5-a]pyrimidin-6-yl)methanone (PubChem CID 164625662) has the molecular formula C19H21N5O and a molecular weight of 335.41 g/mol. Its IUPAC name is [(3S)-1,3-dimethyl-3,4-dihydro-2H-1,5-benzodiazepin-5-yl]-(5-methylpyrazolo[1,5-a]pyrimidin-6-yl)methanone.
Molecular Properties
| Compound Name | [(3S)-1,3-dimethyl-3,4-dihydro-2H-1,5-benzodiazepin-5-yl]-(5-methylpyrazolo[1,5-a]pyrimidin-6-yl)methanone |
|---|---|
| PubChem CID | 164625662 |
| Molecular Formula | C19H21N5O |
| Molecular Weight | 335.41 g/mol |
| Exact Mass | 335.17 |
| IUPAC Name | [(3S)-1,3-dimethyl-3,4-dihydro-2H-1,5-benzodiazepin-5-yl]-(5-methylpyrazolo[1,5-a]pyrimidin-6-yl)methanone |
| SMILES | Cc1nc2ccnn2cc1C(=O)N1C[C@@H](C)CN(C)c2ccccc21 |
| InChI | InChI=1S/C19H21N5O/c1-13-10-22(3)16-6-4-5-7-17(16)23(11-13)19(25)15-12-24-18(8-9-20-24)21-14(15)2/h4-9,12-13H,10-11H2,1-3H3/t13-/m0/s1 |
| InChIKey | NHFBFXPVVFUAQJ-ZDUSSCGKSA-N |
| XLogP | 2.77 |
| TPSA | 53.74 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 1 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 335.41 |
| LogP ≤ 5 | 2.77 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 164625662 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.